When starting Semaglutide GLP-1 for weight loss , most patients begin on a lower dose that allows the body time to adjust and helps minimize side effects
Adverse events with tirzepatide were mainly gastrointestinal-related and mostly mild to moderate in severity
1,4,5 Tirzepatide licensing and funding context Licensing: Although tirzepatide is not licensed for the treatment of type 1 diabetes, it can be prescribed to adults with type 1 diabetes when obesity is the primary indication, provided they meet the MHRA-approved criteria for weight management (BMI 30 kg/m 2 , or BMI 2729.9 kg/m 2 with at least one weight-related health problem)
Ozempic vs Trulicity Dulaglutide is another type of GLP-1 agonist medication sold under the name Trulicity
Kahles F, Liberman A, Halim C, Rau M, Mollmann J, Mertens RW, Ruckbeil M, Diepolder I, Walla B, Diebold S, et al